Exploration of radiotherapy strategy for brain metastasis patients with driver gene positivity in lung cancer.
Ontology highlight
ABSTRACT: Objective: To assess the disparities in effectiveness and identify outcome predictors in the treatment of a targeted-first and radiotherapy-first regimen with driver gene-positive lung cancer brain metastases. Materials and Methods: This retrospective study analyzed patients with driver gene-positive lung cancer brain metastases who received first-targeted and first-radiotherapy regimens, respectively, with SIB-WBRT (whole brain tissue 40 Gy/20 fractions, tumor tissue boosted to 56-60 Gy/20 fractions) and local irradiation (prescription dose range of 20-60 Gy/2-25 fractions, most commonly delivered as 30 Gy/5 fractions, with a BED range of 28-100.8 Gy) at Peking Union Medical College Hospital from September 2015 to December 2021. The primary endpoint was intracranial progress
SUBMITTER: Bi Q
PROVIDER: S-EPMC10905398 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature
ACCESS DATA